Biogen Inc (BIIB)

Net profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net income (ttm)	US$ in thousands	1,161,100	1,461,800	2,664,600	3,131,000	3,046,900	2,864,700	2,059,200	1,449,700	1,556,100	1,545,800	1,918,100	3,011,700	4,000,600	5,082,400	5,926,800	5,878,800	5,888,500	5,395,600	5,294,100	4,666,600
Revenue (ttm)	US$ in thousands	9,835,600	9,993,300	9,971,500	10,104,600	10,173,400	10,363,200	10,633,600	10,819,500	10,981,700	11,100,500	11,697,700	12,604,300	13,444,600	14,263,300	14,487,300	14,422,400	14,377,900	14,232,900	14,071,800	13,811,600
Net profit margin		11.81%	14.63%	26.72%	30.99%	29.95%	27.64%	19.37%	13.40%	14.17%	13.93%	16.40%	23.89%	29.76%	35.63%	40.91%	40.76%	40.96%	37.91%	37.62%	33.79%

December 31, 2023 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $1,161,100K ÷ $9,835,600K
= 11.81%

The net profit margin for Biogen Inc has shown fluctuations over the past eight quarters. In Q1 2023, the net profit margin stood at 30.99%, reflecting the company's ability to convert revenue into profit efficiently during this period. This was a significant increase compared to the previous quarter, Q4 2022, where the net profit margin was 29.95%.

However, there was a notable decline in the net profit margin in Q4 2023 to 11.81%, indicating a decrease in profitability from the previous quarter. This downward trend continued from the peak in Q2 2023, where the net profit margin was at its highest at 26.72%.

Overall, the net profit margin trend for Biogen Inc suggests some degree of volatility in its profitability levels over the past two years. It is important for the company to closely monitor its cost structure, revenue generation, and operational efficiency to maintain a sustainable and healthy level of profitability in the future.